^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Thymoma
    Drug:etoposide IV (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    12/04/2020
    Excerpt:
    Thymomas and Thymic Carcinomas: SECOND-LINE SYSTEMIC THERAPY...THYMOMA...Etoposide